Researchers evaluated coronavirus disease 2019 (COVID-19)-related mortality among perimenopausal women.
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones | Psychedelic Invest
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based